Codominance of cisplatin resistance in somatic cell hybrids

Journal of Cellular Physiology

Volumn 196, Issue 1, 2003, Pages 63-69

  Ying, Yu Lan Mary ^a   Shen, Ding Wu ^a   Liang, Xing Jie ^a   Gottesman, Michael M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; CISPLATIN;

ARTICLE; CARCINOMA CELL; CODOMINANCE; CROSS RESISTANCE; DRUG ACCUMULATION; DRUG RESISTANCE; GENETIC ANALYSIS; HELA CELL; HUMAN; HUMAN CELL; HYBRID CELL; KARYOTYPING; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; SOMATIC CELL; SQUAMOUS CELL CARCINOMA;

ANTINEOPLASTIC AGENTS; CARBOPLATIN; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; CISPLATIN; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, DOMINANT; HELA CELLS; HUMANS; HYBRID CELLS; KB CELLS; METHOTREXATE;

STROPHANTHUS GRATUS;

EID: 0038284071     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.10320     Document Type: Article

References (26)

1. Akiyama SI, Fojo A, Hanover JA, Pastan I, Gottesman MM. 1985. Isolation and genetic characterization of human KB cell lines resistant to multiple drugs. Somat Cell Mol Genet 11:117-126.
2. Barnes DE, Lindahl T, Sedgwick B. 1993. DNA repair. Curr Opin Cell Biol 5:424-433.
3. Basu A, Weixel K, Saijo N. 1996. Characterization of the protein kinase C signal transduction pathway in cisplatin-sensitive and -resistant human small cell lung carcinoma cells. Cell Growth Differ 7:1507-1512.
4. Boni LT, Hui SW. 1987. The mechanism of polyethylene glycol induced fusion in model membranes. Cell Fusion 14:301-330.
5. Chu G. 1994. Cellular responses to cisplatin. The role of DNA-binding proteins and DNA repair. J Biol Chem 269:787-790.
6. Eastman A, Richon VM. 1986. Mechanisms of cellular resistance to platinum coordination complexes. In: McBrien DCH, Slater TF, editors. Biochemical mechanisms of the platinum antitumor drugs. Oxford, England: IRL Press Ltd. p 91-119.
7. Fink D, Aebi S, Howell SB. 1998. The role of DNA mismatch repair in drug resistance. Clin Cancer Res 4:1-5.
8. Gately DP, Howell SB. 1993. Cellular accumulation of the anticancer agent cisplatin: A review. Br J Cancer 67:1171-1176.
9. Gottesman MM. 1987. Drug-resistant mutants: Selection and dominance analysis. Methods Enzymol 151:113-121.
10. Ishida S, Lee J, Thiele DJ, Herskowitz I. 2002. Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals. Proc Natl Acad Sci USA 99:14298-14302.
11. Johnson SW, Shen DW, Pastan I, Gottesman MM, Hamilton TC. 1996. Cross-resistance, cisplatin accumulation, and platinum-DNA adduct formation and removal in cisplatin-sensitive and -resistant human hepatoma cell lines. Exp Cell Res 226:133-139.
12. Kasahra K, Fujiwara YA, Nishio K. 1991. Metallothionein content correlates with the sensitivity of human small cell lung cancer cell lines to cisplatin. Cancer Res 51:3237-3242.
13. Kondo S, Barna BP, Kondo Y, Tanaka Y, Cassey G, Liu J, Morimura T, Kaakaji R, Peterson JW, Werbel B, Barnett GH. 1996. WAF1/CIP1 increases the susceptibility of p53 non-functional malignant glioma cells to cisplatin-induced apoptosis. Oncogene 13:1279-1285.
14. Lai SL, Hwang J, Perng RP. 1995. Modulation of cisplatin resistance in acquired-resistant non small cell lung cancer cells. Oncol Res 7:31-38.
15. Liang XJ, Shen DW, Garfield S, Gottesman MM. 2003. Mislocalization of membrane proteins associated with multidrug resistance in cisplatin-resistant cancer cell lines. Submitted.
16. Ling V, Baker RM. 1978. Dominance of colchicine resistance in hybrid CHO cells. Somat Cell Genet 4:193-200.
17. Liu B, Cvijic ME, Jetzt A, Chin KV. 1996. Cisplatin resistance and regulation of DNA repair in cAMP-dependent protein kinase mutants. Cell Growth Differ 7:1105-1112.
18. Moscow JA, Cowan KH. 1988. Multidrug resistance. J Natl Cancer Inst 80:14-20.
19. Richon VM, Schulte N, Eastman A. 1987. Multiple mechanisms of resistance to cis-diamminedichloroplatinum(II) in murine leukemia L1210 cells. Cancer Res 47:2056-2061.
20. Ruan S, Okcu MF, Reb JP, Chiao P, Andreeff M, Levin V, Zhang W. 1998. Overexpressed WAS1/Clip 1 rends glioblastoma cells resistant to chemotherapy agents 1,3-bis(2-chlorethyl)-1-nitrosourea and cisplatin. Cancer Res 58:1538-1543.
21. Shellard SA, Hosking LK, Hill BT. 1991. Anomalous relationship between cisplatin sensitivity and the formation and removal of platinum-DNA adducts in two human ovarian carcinoma cell lines in vitro. Cancer Res 51:4557-4564.
22. Shen D-W, Pastan I, Gottesman MM. 1998. Cross-resistance to methotrexate and metals in human cisplatin-resistant cell lines results from a pleiotropic defect in accumulation of these compounds associated with reduced plasma membrane binding proteins. Cancer Res 58:268-275.
23. 14C] carboplatin in human cisplatin-resistant cells results from reduced energy-dependent uptake. J Cell Physiol 183:108-116.
24. Timmer-Bosscha H, Mulder NH, de Vries EG. 1992. Modulation of cisdiamminedichloroplatinum(II) resistance: A review. Br J Cancer 66:227-238.
25. Wang X, Majid H, Masters RW. 1996. Genetic basis of drug sensitivity in human testis tumour cells. Int J Cancer 65:426-431.
26. Weissman B, Stanbridge EJ. 1980. Characterization of ouabain resistant, hypoxanthine phosphoribosyl transferase deficient human cells and their usefulness as a general method for the production of human cell hybrids. Cytogenet Cell Genet 28:227-239.